COVID-19 Impact on Alpha Blockers Market, Global Research Reports 2020-2021
Table of Contents1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Alpha Blockers Industry
1.7 COVID-19 Impact: Alpha Blockers Market Trends
2 Global Alpha Blockers Quarterly Market Size Analysis
2.1 Alpha Blockers Business Impact Assessment - COVID-19
2.1.1 Global Alpha Blockers Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Alpha Blockers Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Alpha Blockers Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 Global Alpha Blockers Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Alpha Blockers Factory Price by Manufacturers
3.3 Location of Key Manufacturers Alpha Blockers Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Alpha Blockers Market
3.5 Key Manufacturers Alpha Blockers Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Alpha Blockers Segments, By Type
4.1 Introduction
1.4.1 Non-selective Antagonists
1.4.2 Selective Antagonists
4.2 By Type, Global Alpha Blockers Market Size, 2019-2021
4.2.1 By Type, Global Alpha Blockers Market Size by Type, 2020-2021
4.2.2 By Type, Global Alpha Blockers Price, 2020-2021
5 Impact of Covid-19 on Alpha Blockers Segments, By Application
5.1 Overview
5.5.1 Hypertension
5.5.2 Raynaud's Disease
5.5.3 Erectile Dysfunction
5.2 By Application, Global Alpha Blockers Market Size, 2019-2021
5.2.1 By Application, Global Alpha Blockers Market Size by Application, 2019-2021
5.2.2 By Application, Global Alpha Blockers Price, 2020-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Business Overview
7.1.2 Pfizer Alpha Blockers Quarterly Production and Revenue, 2020
7.1.3 Pfizer Alpha Blockers Product Introduction
7.1.4 Pfizer Response to COVID-19 and Related Developments
7.2 Novartis
7.2.1 Novartis Business Overview
7.2.2 Novartis Alpha Blockers Quarterly Production and Revenue, 2020
7.2.3 Novartis Alpha Blockers Product Introduction
7.2.4 Novartis Response to COVID-19 and Related Developments
7.3 Merck
7.3.1 Merck Business Overview
7.3.2 Merck Alpha Blockers Quarterly Production and Revenue, 2020
7.3.3 Merck Alpha Blockers Product Introduction
7.3.4 Merck Response to COVID-19 and Related Developments
7.4 Astra Zeneca
7.4.1 Astra Zeneca Business Overview
7.4.2 Astra Zeneca Alpha Blockers Quarterly Production and Revenue, 2020
7.4.3 Astra Zeneca Alpha Blockers Product Introduction
7.4.4 Astra Zeneca Response to COVID-19 and Related Developments
7.5 Jhonson and Johnson
7.5.1 Jhonson and Johnson Business Overview
7.5.2 Jhonson and Johnson Alpha Blockers Quarterly Production and Revenue, 2020
7.5.3 Jhonson and Johnson Alpha Blockers Product Introduction
7.5.4 Jhonson and Johnson Response to COVID-19 and Related Developments
7.6 Eli Lilly
7.6.1 Eli Lilly Business Overview
7.6.2 Eli Lilly Alpha Blockers Quarterly Production and Revenue, 2020
7.6.3 Eli Lilly Alpha Blockers Product Introduction
7.6.4 Eli Lilly Response to COVID-19 and Related Developments
7.7 Sanofi
7.7.1 Sanofi Business Overview
7.7.2 Sanofi Alpha Blockers Quarterly Production and Revenue, 2020
7.7.3 Sanofi Alpha Blockers Product Introduction
7.7.4 Sanofi Response to COVID-19 and Related Developments
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Business Overview
7.8.2 Bristol-Myers Squibb Alpha Blockers Quarterly Production and Revenue, 2020
7.8.3 Bristol-Myers Squibb Alpha Blockers Product Introduction
7.8.4 Bristol-Myers Squibb Response to COVID-19 and Related Developments
7.9 Bayer
7.9.1 Bayer Business Overview
7.9.2 Bayer Alpha Blockers Quarterly Production and Revenue, 2020
7.9.3 Bayer Alpha Blockers Product Introduction
7.9.4 Bayer Response to COVID-19 and Related Developments
7.10 GSK
7.10.1 GSK Business Overview
7.10.2 GSK Alpha Blockers Quarterly Production and Revenue, 2020
7.10.3 GSK Alpha Blockers Product Introduction
7.10.4 GSK Response to COVID-19 and Related Developments
7.11 Teva Pharmaceutical
7.11.1 Teva Pharmaceutical Business Overview
7.11.2 Teva Pharmaceutical Alpha Blockers Quarterly Production and Revenue, 2020
7.11.3 Teva Pharmaceutical Alpha Blockers Product Introduction
7.11.4 Teva Pharmaceutical Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
8.1 Alpha Blockers Supply Chain Analysis
8.1.1 Alpha Blockers Supply Chain Analysis
8.1.2 Covid-19 Impact on Alpha Blockers Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Alpha Blockers Distribution Channels
8.2.2 Covid-19 Impact on Alpha Blockers Distribution Channels
8.2.3 Alpha Blockers Distributors
8.3 Alpha Blockers Customers
9 Key Findings
10 Appendix
10.1 About Us
10.2 Disclaimer
List of TablesTable 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Alpha Blockers Assessment
Table 9. COVID-19 Impact: Alpha Blockers Market Trends
Table 10. COVID-19 Impact Global Alpha Blockers Market Size
Table 11. Global Alpha Blockers Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Alpha Blockers Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Alpha Blockers Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Alpha Blockers Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Alpha Blockers Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Alpha Blockers Market Growth Drivers
Table 17. Global Alpha Blockers Market Restraints
Table 18. Global Alpha Blockers Market Opportunities
Table 19. Global Alpha Blockers Market Challenges
Table 20. Key Manufacturers Alpha Blockers Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Alpha Blockers Market Size, 2019 (K Units) & (US$ Million)
Table 22. Alpha Blockers Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Alpha Blockers Manufacturing Plants
Table 24. Key Manufacturers Alpha Blockers Market Served
Table 25. Date of Key Manufacturers Enter into Alpha Blockers Market
Table 26. Key Manufacturers Alpha Blockers Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Alpha Blockers Market Size by Type, 2020, (US$ Million)
Table 29. Global Alpha Blockers Market Size by Type, 2020 (K Units)
Table 30. Global Alpha Blockers Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Alpha Blockers Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Alpha Blockers Market Size by Application, 2020-2021 (K Units)
Table 33. Global Alpha Blockers Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Alpha Blockers Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Alpha Blockers Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Alpha Blockers Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Alpha Blockers Market Size, 2019-2021 (K Units)
Table 38. US Alpha Blockers Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Alpha Blockers Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Alpha Blockers Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Alpha Blockers Market Size, 2019-2021 (K Units)
Table 43. Germany Alpha Blockers Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Alpha Blockers Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Alpha Blockers Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Alpha Blockers Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Alpha Blockers Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Alpha Blockers Market Size, 2019-2021 (K Units)
Table 50. China Alpha Blockers Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Alpha Blockers Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Alpha Blockers Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Alpha Blockers Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Alpha Blockers Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Alpha Blockers Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Alpha Blockers Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. Pfizer Business Overview
Table 58. Pfizer Alpha Blockers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Pfizer Alpha Blockers Product
Table 60. Pfizer Response to COVID-19 and Related Developments
Table 61. Novartis Business Overview
Table 62. Novartis Alpha Blockers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Novartis Alpha Blockers Product
Table 64. Novartis Response to COVID-19 and Related Developments
Table 65. Merck Business Overview
Table 66. Merck Alpha Blockers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Merck Alpha Blockers Product
Table 68. Merck Response to COVID-19 and Related Developments
Table 69. Astra Zeneca Business Overview
Table 70. Astra Zeneca Alpha Blockers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Astra Zeneca Alpha Blockers Product
Table 72. Astra Zeneca Response to COVID-19 and Related Developments
Table 73. Jhonson and Johnson Business Overview
Table 74. Jhonson and Johnson Alpha Blockers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Jhonson and Johnson Alpha Blockers Product
Table 76. Jhonson and Johnson Response to COVID-19 and Related Developments
Table 77. Eli Lilly Business Overview
Table 78. Eli Lilly Alpha Blockers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Eli Lilly Alpha Blockers Product
Table 80. Eli Lilly Response to COVID-19 and Related Developments
Table 81. Sanofi Business Overview
Table 82. Sanofi Alpha Blockers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Sanofi Alpha Blockers Product
Table 84. Sanofi Response to COVID-19 and Related Developments
Table 85. Bristol-Myers Squibb Business Overview
Table 86. Bristol-Myers Squibb Alpha Blockers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Bristol-Myers Squibb Alpha Blockers Product
Table 88. Bristol-Myers Squibb Response to COVID-19 and Related Developments
Table 89. Bayer Business Overview
Table 90. Bayer Alpha Blockers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Bayer Alpha Blockers Product
Table 92. Bayer Response to COVID-19 and Related Developments
Table 93. GSK Business Overview
Table 94. GSK Alpha Blockers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. GSK Alpha Blockers Product
Table 96. GSK Response to COVID-19 and Related Developments
Table 97. Teva Pharmaceutical Business Overview
Table 98. Teva Pharmaceutical Alpha Blockers Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Teva Pharmaceutical Alpha Blockers Product
Table 100. Teva Pharmaceutical Response to COVID-19 and Related Developments
Table 101. Alpha Blockers Distributors List
Table 102. Alpha Blockers Customers List
Table 103. Covid-19 Impact on Alpha Blockers Customers
List of FiguresFigure 1. Alpha Blockers Product Picture
Figure 2. Alpha Blockers Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Alpha Blockers Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Alpha Blockers Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Alpha Blockers Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Alpha Blockers Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Alpha Blockers Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Alpha Blockers Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Alpha Blockers Market Size Market Share, 2019-2021